Verrica Pharmaceuticals Inc. Common Stock (VRCA) is a publicly traded Healthcare sector company. As of May 21, 2026, VRCA trades at $6.14 with a market cap of $100.84M and a P/E ratio of -5.37. VRCA moved +6.80% today. Year to date, VRCA is -32.13%; over the trailing twelve months it is -6.39%. Its 52-week range spans $3.28 to $17.49. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces VRCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Verrica Pharmaceuticals Inc. Common Stock (VRCA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VRCA moved +6.80% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $6.14 |
| Market Cap | $100.84M |
| P/E Ratio | -5.37 |
| EPS | $-1.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.49 |
| 52-Week Low | $3.28 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $37.16M |
| Net Income | $-17.83M |
| Gross Margin | 0.00% |
2 analysts cover VRCA: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.00.